Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges
| Condition | Alzheimer Disease, Mild Cognitive Impairment, Dementia |
|---|---|
| Phase | N/A |
| Sponsor | Brigham and Women's Hospital |
| Status | Completed |
| Enrollment | 262 participants |
| Interventions | Nudge Intervention |
| Start date | Aug 1, 2024 |
| Completion date | Oct 14, 2025 |
| Results posted | Jul 30, 2026 |
Summary
The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.
Composite of the Percentage of Eligible PCPs or Their PLWD/Care Partners Who View or Click on Information on or Before the Primary Care Provider Visit, up to 10 Days
| Nudge Intervention | 103 Participants |
|---|
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University